Advanced glycation end-products in myocardium-supported vessels: Effects of heart failure and diabetes mellitus

Journal of Heart and Lung Transplantation

Volumn 30, Issue 5, 2011, Pages 558-564

  Noyski, Jerzy ^a   Zakliczyski, Micha ^a   Konecka Mrwka, Dominika ^a   Przybylski, Roman ^a   Zembala, Marian ^a   Zieliska, Teresa ^a   Mrwka, Andrzej ^a   Lange, Dariusz ^b   Zembala Noyska, Ewa ^b   Nikiel, Barbara ^b   Mynarczyk Liszka, Joanna ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

advanced glycation end products; cardiomyopathy; coronary artery; diabetes mellitus type 2; heart failure; heart transplantation; myocardial vessels

Indexed keywords

ADVANCED GLYCATION END PRODUCT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY BLOOD VESSEL; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AUTOPSY; CAPILLARIES; CASE-CONTROL STUDIES; CHRONIC DISEASE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; VEINS;

EID: 79953793536     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.11.006     Document Type: Article

References (22)

1. E.D. Schleicher, E. Wagner, and A.G. Nerlich Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging J Clin Invest 99 1997 457 468 (Pubitemid 27414803)
2. S.Y. Goh, and M.E. Cooper Clinical review: The role of advanced glycation end products in progression and complications of diabetes J Clin Endocrinol Metab 93 2008 1143 1152 (Pubitemid 351519698)
3. F. Piarulli, G. Sartore, and A. Ceriello Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients Diabetologia 52 2009 1419 1425
4. L.J. Sparvero, D. Asafu-Adjei, and R. Kang RAGE (receptor for advanced glycation endproducts), RAGE ligands and their role in cancer and inflammation J Trans Med 7 2009 17 34
5. S. Yamagishi Advanced glycation end products and receptoroxidative stress system in diabetic vascular complications Ther Apher Dial 13 2009 534 539
6. J.W. Hartog, A.A. Voors, and C.G. Schalkwijk Clinical and prognostic value of advanced glycation end-products in chronic heart failure Eur Heart J 28 2007 2879 2885 (Pubitemid 350233041)
7. J. Nozyski, M. Zakliczyski, and D. Konecka-Mrwka Advanced glycation end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2 Transplant Proc 41 2009 99 104
8. X. Ling, N. Sakashita, and M. Takeya Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues Lab Invest 78 1998 1591 1606 (Pubitemid 29022235)
9. X. Ling, R. Nagai, and N. Sakashita Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats with streptozotocin-induced diabetes Lab Invest 81 2001 845 861 (Pubitemid 32553406)
10. Y. Nakamura, Y. Horii, and T. Nishino Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus Am J Pathol 143 1993 1649 1656 (Pubitemid 24058268)
11. N. Tanji, G.S. Markowitz, and C. Fu Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease J Am Soc Nephrol 11 2000 1656 1666
12. ε- (carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels Atherosclerosis 174 2004 287 292 (Pubitemid 38597085)
13. C.G. Schalkwijk, A. Baidoshvili, and C.D. Stehouwer Increased accumulation of the glycoxidation product N epsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterization of a monoclonal anti-CML antibody Biochim Biophys Acta 1636 2004 82 89 (Pubitemid 38780784)
14. K. Kamata, Y. Ozawa, and T. Kobayashi Effect of N-epsilon-(carboxymethyl) lysine on coronary vasoconstriction in isolated perfused hearts from control and streptozotocin-induced diabetic rats J Smooth Muscle Res 45 2009 125 137
15. K.C. Chang, K.L. Hsu, and C.D. Tseng Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats Br J Pharmacol 147 2006 944 950
16. R. Karch, F. Neumann, and R. Ullrich The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy Cardiovasc Pathol 14 2005 135 144 (Pubitemid 40725589)
17. E.P. Tsagalou, M. Anastasiou-Nana, and E. Agapitos Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy J Am Coll Cardiol 52 2008 1391 1398
18. J.D. Furber Extracellular glycation crosslinks: prospects for removal Rejuv Res 9 2006 274 278 (Pubitemid 43856819)
19. B.P. Shapiro, T.E. Owan, and S.F. Mohammed Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines Circulation 118 2008 1002 1010
20. N. Nazratun, A.A. Mahmood, and U.R. Kuppusamy Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients Vasc Med 11 2006 245 250 (Pubitemid 46470503)
21. M. Zakliczynski, J. Nozynski, and D. Konecka-Mrowka Different role of advanced glycation end products in pathology of transplanted heart in patients with or without diabetes mellitus type 2 Transplant Proc 41 2009 3185 3189
22. M.R. Mehra Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy Am J Transplant 6 2006 1248 1256 (Pubitemid 44030306)